OBJECTIVE: To examine the expression of peroxisome proliferator-activated receptor g (PPARg) together with CCAATaenhancer binding protein a (CaEBPa), lipoprotein lipase (LPL) and glucose transporter (GLUT4) mRNA in adipose tissue of rhesus monkeys in relation to obesity. DESIGN: Cloning of the PPARg1 and g2 cDNAs and analysis of PPARg, CaEBPa, LPL and GLUT4 mRNA levels in the adipose tissue of lean and obese monkeys. SUBJECTS: 28 rhesus monkeys (Macaca mulatta) with a wide range of body weights (9.2 ± 22.6 kg) and with or without type 2 diabetes. MEASUREMENTS: Sequence of PPARg1 and g2. Tissue distribution of PPARg1 and g2. The mRNA levels of PPARg, CaEBPa, LPL and GLUT4 in adipose tissue. The ratio of PPARg2 mRNA to total PPARg mRNA. RESULTS: The monkey PPARg2 protein showed 99% identity with the human protein. PPARg1 mRNA was shown to be expressed in various tissues and most abundantly in adipose tissue. PPARg2 existed mainly in adipose tissue. A signi®cant correlation between the ratio of PPARg2 mRNA to total PPARg mRNA and obesity was observed, whereas total PPARg mRNA levels showed no signi®cant relationships to obesity. There was also a signi®cant relationship between the ratio of PPARg2 mRNA to total PPARg mRNA and fasting plasma insulin concentration. The mRNA levels of CaEBPa, LPL and GLUT4 were highly correlated to that of total PPARg mRNA. They were also signi®cantly correlated to the mRNA levels of PPARg1 and PPARg2. CONCLUSIONS: The ratio of PPARg2 mRNA to total PPARg mRNA is related to obesity in the rhesus monkey and mRNA expression of PPARg1, PPARg2, CaEBPa, LPL and GLUT4 appear to be coordinated in vivo.
Introduction
Many rhesus monkeys (Macaca mulatta) become obese during middle age. 1 Obese rhesus monkeys, as in humans, are usually insulin resistant and hyperinsulinaemic, and frequently develop type 2 diabetes. 2 Obesity in the rhesus monkey is accompanied by both increased adipose cell size (hypertrophic obesity) and increased cell number (hyperplastic obesity). 3 These facts support the rhesus monkey as an excellent model for the study of human obesity and type 2 diabetes. 1 Peroxisome proliferator-activated receptor g (PPARg) is a member of the PPAR subfamily of nuclear hormone receptors. 4±6 There are two isoforms of PPARg (g1 and g2), which are formed by alternative splicing, 7 resulting in distinct N-termini.
8±10
PPARg2 is highly expressed in adipocytes, while PPARg1 is expressed in many tissues. 10±13 PPARg expression is induced very early during adipose cell differentiation. 5, 6, 10, 11 Forced expression of PPARg2 or PPARg1 in ®broblasts, was suf®cient to drive the determination of an adipocyte cellular lineage. 13 Furthermore, ectopic expression of PPARg and CCAATaenhancer binding protein a (CaEBPa) in cultured myoblasts, resulted in a switch from myogenesis to adipogenesis.
14 PPARg forms a heterodimer with retinoid X receptor a (RXRa) and has been shown to bind directly to fat-speci®c enhancers from the adipocyte P2 (aP2), 15 and phosphoenolpyruvate carboxykinase (PEPCK) genes. 16 PPARg is activated by drugs that cause peroxisome proliferation such as clo®brate, 5,8,11,14-eicosatetraynoic acid (ETYA), and Wy14,643, as well as by a variety of other fatty acid derivatives. 11, 17, 18 Recently, ligands for PPARg have been described including 15-deoxy-D 12, 14 -prostaglandin J 2 and thiazolidinediones.
19±21
Thiazolidinediones are a class of antidiabetic agent that increase the sensitivity of target tissues to the action of insulin. 22 Although PPARg has been shown to play an important role in adipocyte differentiation and in the mechanism of thiazolidinedione action, few studies in vivo have been reported. Recent studies showed that the levels of PPARg1 and PPARg2 expression in adipose tissue were modestly increased in toxigeneinduced brown fat ablated mice, but were not altered in two other murine models of obesity (gold thioglucose and obaob). 12 Recently, Vidal-Puig et al 23 have reported that the mRNA levels of PPARg2 and the ratio of PPAR g1ag2 splice variants increased in the adipose tissue of obese humans. Thus, there appear to be species differences in the obesity-related expression of PPARg2. The potential role of PPARg in the development or maintenance of obesity is not clear.
We now report the cloning of the rhesus monkey PPARg1 and PPARg2 cDNAs, together with examination of the expression of this gene in relation to body weight (adiposity) and plasma insulin levels in adult monkeys of various ages and weights. Results showed that the ratio of PPARg2 mRNA to total PPARg mRNA was signi®cantly related to body weight and to fasting plasma insulin, whereas neither total PPARg, PPARg1 nor PPARg2 mRNA levels was correlated to body weight (obesity) or fasting plasma insulin.
Methods

Animals
Twenty-eight rhesus monkeys (Macaca mulatta) were studied. They were maintained individually in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals. They were provided 8 had access to either Ensure 1 (Ross Laboratories, Columbus, OH), a nutritionally complete liquid diet or monkey chow 1 (Purina Mills Inc., St Louis, MO) and fresh water ad libitum. The normal monkeys (n 10) were lean (body weight: 10.2 AE 0.6 kg and body fat: 18.1 AE 3.3%) and their fasting plasma glucose (3.3AE 0.1 mM) and insulin (324 AE 31 pM) concentrations were normal. The obese monkeys (n 10) (body weight: 17.9AE 1.0 kg and body fat: 33.4 AE 2.1%) were normoglycaemic (4.0AE 0.1 mM) and hyperinsulinaemic (1066AE 144 pM). The body weight (12.7 AE 1.4 kg), body fat (35.5 AE 3.0%) and fasting plasma insulin concentrations (363 AE 100 pM) of the type 2 diabetic monkeys (n 8) (fasting plasma glucose: 10.7AE 0.9 mM) were decreased as compared with obese monkeys. In adult rhesus monkeys, aged b 10 y, body weight is highly correlated to % body fat. 3, 24 Four of the type 2 diabetic monkeys were receiving insulin treatment. No insulin was given on the day tissues were obtained.
Procedures
Plasma samples for fasting glucose and insulin were obtained under light anaesthesia (ketamine hydrochloride 10 mgakg body weight with dose repeated as necessary), following a consistent 16 h fast. Plasma was frozen for later assays. Abdominal subcutaneous adipose tissue samples were taken under either ketamine hydrochloride, as described above, or sodium pentobarbital. Tissue samples were immediately frozen and stored at 7165 C.
Cloning of the monkey PPARg
The forward primers, PPAR1 
H RACE, ®rst strand cDNA was synthesized using the 3 H RACE system for Rapid Ampli®cation of cDNA Ends (Life Technologies, Gaithersburg, MD) and PCR was performed using the universal ampli®cation primer (Life Technologies, Gaithersburg, MD) and PPAR7. The PCR products were subcloned into pCR2.1 (Invitorgen Co., Carlsbad, CA) and sequenced.
Northern and slot blot hybridization analysis
Total RNA was prepared using TRIzol reagent (Life Technologies, Gaithersburg, MD). The concentration was determined by absorbance measurements at 260 nm. 20 mg of total RNA was separated by 0.8% agarose gel containing 2.2 M formaldehyde and transferred to a nylon membrane (Hybond TM -N, Amersham, Buckinghamshire, England). 3 mg of total RNA was applied to a nitrocellulose ®lter using a slot blot apparatus (Bio-Rad Laboratories, Hercules, CA). To con®rm the linearity of the densitometry, 1 mg, 2 mg and 3 mg of total RNA from some samples were applied on each ®lter. The membranes and ®lters were prehybridized at 42 C for 4 h in the solution containing 50% formamide, 5X Denhardt's, 6X SSC, 20 mM sodium phosphate (pH 6.5), 1% SDS, and 100 mgaml denatured salmon sperm DNA. 26, 27 The hybridization was carried out at 42 C for 24 h in the same condition noted above, except containing 1 Â 10 6 cpmaml 32 P-labeled probe. Filters were washed with 0.1X SSC, 0.1% SDS twice at room temperature and twice at 65 C. 26, 27 Monkey partial CaEBPa, lipoprotein lipase (LPL), glucose transporter (GLUT4), aP2 and PEPCK cDNAs were ampli®ed by RT-PCR using the following primer sets. CaEBPa, 5
H -GCGCGAATTCAGGC-CAAGAAGTCGGTGGACAA-3 H and 5
H and 5
H -CGCGCTCGAGGTTGTAGCCAAAGAAGGGC-CGCA-3 H . These oligonucleotides were synthesized according to human or mouse sequences 28±32 and included EcoRI, Xhol or XbaI restriction sites. The DNA fragments were cloned into pBluescriptII KS () (Stratagene, La Jolla, CA) and sequenced to con®rm that these PCR fragments were homologous to the human genes. These fragments represented human CaEBPa (818-1069), LPL (129-1112), GLUT4 (422-1327), aP2 (1-380) and PEPCK (246-1467). The fragment ampli®ed using PPAR3 and PPAR4 primers was used as a probe for PPARg.
Heat shock protein (HSP83) was used as an internal control. 27, 33 The relative amounts of these probes bound to the immobilized mRNAs were quantitated by densitometry (Molecular Dynamics, Sunnyvale, CA) and normalized to the HSP83 mRNA levels. Expression of PPARg1 and PPARg2 in obese monkeys K Hotta et al
Analysis of splicing alternatives of monkey PPARg
The following primers were synthesized. PPAR8 (common to both PPARg1 and g2), 5 H -GGATC-TGTTCTTGTGAATGGAA-3 H ; PPAR9 (common to both PPARg1-a and PPARg1-b sequence), 5
H -GAAA-GAAGCCAACACTAAACCA-3 H ; PPAR10 (speci®c to PPARg2 sequence), 5
H -CACTGTCTGCAAACA-TATCACA-3 H ; PPAR11 (speci®c to PPARg1-a), 5 H -AAGAAGGCTGCATTTCTGCATT-3 H ; and PPAR12 (speci®c to PPARg1-b), 5
H -ACACCGGACAGGGG-CGCCACGC-3 H ( Figure 1A ). RT-PCR was performed from various tissues of monkey as described above. PCR products were separated on 3% agarose.
The relative amounts of mRNA corresponding to PPARg1 and PPARg2 were measured as described, 34 with some modi®cations. Brie¯y, reverse transcription was performed as described above. PCR was performed using primers (PPAR8, PPAR9 and PPAR10) in the same reaction concentration except adding 1 mCiatube of a-[ 32 P] dCTP (3000 Ciammol, Amersham, Buckinghamshire, England). PCR conditions were essentially the same as those described above, except 20 cycles were performed. Two resulting radiolabeled PCR products were separated on an 8% polyacrylamide gel. The gel was dried and autoradiography was performed. The relative amounts of two splicing variants were quantitated by densitometry (Molecular Dynamics, Sunnyvale, CA) and corrected for GC content and lengths of PPARg1 and PPARg2 PCR products. The PCR products which were made by using PPAR11 and PPAR2 (PPARg1), and PPAR1 and PPAR2 (PPARg2) were cloned. Known ratios of the in vitro synthesized RNA from the above clones using T7 RNA polymerase (Life Technologies, Gaithersburg, MD) were reverse transcribed and ampli®ed as described above.
Other assays
Plasma glucose was assayed using a Beckman glucose autoanalyzer II (Beckman Instruments, Fullerton, CA) and plasma insulin was determined by radioimmunoassay. 35 Body fat was determined using the tritiated water dilution method. 36 
Statistical analysis
Data are expressed as the mean AE s.e.m. Differences in subcutaneous and omental adipose tissue were determined using a paired t-test. Linear relationships between key variables were tested using Pearson's correlation coef®cient.
Results
To examine mRNA levels in spontaneously obese and in type 2 diabetic rhesus monkeys, we ®rst used a PCRbased cloning strategy to obtain monkey PPARg cDNA. As previously reported in the mouse 7±10 and human, 25, 37 there were two isoforms of monkey PPARg, that is PPARg1 and PPARg2, which were produced by alternative splicing at the 5 H -end. This alternative splicing of PPARg2 occurred in the 5 H noncoding region of PPARg1 ( Figure 1A) . The 5 H -end sequence speci®c to PPARg2 contained another start codon. Thus, as reported in mouse, 7,10 the monkey PPARg2 protein was identical to PPARg1 with the exception that it had an additional 30 N-terminal amino acids ( Figure 1B) . During the cloning process, we found that there were two splicing alternatives in monkey PPARg1 ( Figure 1A) . These alternative splicings occurred in the 5
H non-coding region of PPARg1, thus, both PPARg1 isoforms would be predicted to utilize the same start codon. The putative amino acid sequence of PPARg2 has high identity with the human (99%) 25, 37 and mouse (96%) proteins 10 ( Figure 1B ). Most differences between rodent and primate sequences were in the PPARg2 speci®c region where the identity between monkey and mouse was 67%. The full length of monkey PPARg1-a, PPARg1-b and PPARg2 cDNA sequences are available in GenBank (accession number: PPARg1-a; AF033342, PPARg1-b; AF033343, PPARg2; AF033103). Northern blot analysis revealed that the monkey PPARg probe hybridized to a single broad band which was about 2 kb. PPARg was highly expressed in adipose tissue and it was also expressed in other tissues at lower levels including liver, heart, kidney, stomach, duodenum and colon, as has been reported in mouse and human tissues 10 ± 13,23,25,37 ( Figure 2A ). Since the probe used in the Northern blot analysis was common to the sequence of both PPARg1 and PPARg2, it did not discriminate between the two isoforms. Thus, we performed RT-PCR to examine the tissue distribution of these isoforms. PPARg1 (sum of PPARg1-a and PPARg1-b) existed in all tissues, whereas, PPARg2 existed mainly in adipose tissue, as reported in mouse 7,10,11 and human 23, 25, 37 ( Figure  2B ). The two alternatively spliced products of PPARg1, that is PPARg1-a and PPARg1-b, existed in all tissues examined ( Figure 2B) .
Next, we examined the mRNA expression levels of PPARg, and other adipocyte differentiation-related genes, including CaEBPa, LPL, GLUT4, aP2 and PEPCK, in subcutaneous adipose tissue in normal, obese and type 2 diabetic monkeys. We performed the Northern blot analysis using CaEBPa, LPL, GLUT4, aP2 and PEPCK probes to con®rm that these probes hybridized to speci®c bands (Figure 3) . The mRNA levels of all of these genes showed no correlation to body weight or adiposity (Figure 4) . They also showed no correlation to fasting plasma insulin (data not shown). However, the mRNA levels of total PPARg (sum of PPARg1-a, PPARg1-b and PPARg2) were highly correlated to the mRNA levels of CaEBPa (r 0.664, P`0.001), LPL (r 0.798, P`0.001) and GLUT4 (r 0.773 P`0.001), but not to that of aP2 (r 0.314) or PEPCK (Figure 5 ). The mRNA levels of CaEBPa, LPL and GLUT4 were signi®cantly correlated to the mRNA levels of both PPARg isoforms, which were calculated from data of slot blots and of RT-PCR described below. The correlations of CaEBPa, LPL and GLUT4 were greater to PPARg1 (sum of PPARg1-a and PPARg1-b) than to PPARg2. CaEBPa and PPARg1 (r 0.659, P`0.001), CaEBPa and PPARg2 (r 0.490, P`0.01), LPL and PPARg1 (r 0.727, P`0.001), LPL and PPARg2 (r 0.696, P`0.001), GLUT4 and PPARg1 (r 0.786, P`0.001), GLUT4 and PPARg2 (r 0.540, P`0.01). There were no signi®-cant correlations between the mRNA levels of either PPARg1 or PPARg2 and those of aP2 (PPARg1; r 0.256, PPARg2; r 0.322) or PEPCK (PPARg1; r 0.059, PPARg2; r 7 0.233).
Expression of PPARg1 and PPARg2 in obese monkeys
We next analyzed the ratio of PPARg1 and PPARg2. Since PPARg1-a and PPARg1-b had the same coding sequence, and the region of differences was very small, we examined the ratio of PPARg2 to the sum of the PPARg1-a, PPARg1-b and PPARg2 (total PPARg). To determine if these two mRNA splicing variants were being ampli®ed in an unbiased manner, a validation experiment was performed. In vitro synthesized PPARg1 and PPARg2 were mixed in varying ratios and RT-PCR was performed ( Figure  6A,B) . The observed ratio of PPARg2 mRNA to total PPARg mRNA (%PPARg2) was highly correlated to the expected one (r 0.990), con®rming that the two splicing mRNA variants were being ampli®ed in an unbiased manner ( Figure 6B) . A cycle titration revealed that 20 cycles was within the logarithmic phase of ampli®cation (19±25 cycles, r 0.997).
Next, we examined the ratio of PPARg2 mRNA to total PPARg mRNA in subcutaneous adipose tissue in the same monkeys used above. The ratio of PPARg2 mRNA to total PPARg mRNA was highly correlated to body weight which, in turn, in adult monkeys, is highly related to adiposity (r 0.615, P`0.001, Figure 6C ). Four monkeys were outliers, relative to the other monkeys. Three of those monkeys were diabetic and receiving insulin treatment, and had lost isolated from various tissues was applied to each lane. Northern blot analysis was carried out as described under methods. B, RT-PCR analysis of PPARg alternative splicing. RT-PCR was carried out as described under methods. Primers PPAR8, PPAR9 and PPAR10 were used for ampli®cation of PPARg1 and PPARg2. A set of primers (PPAR8 and PPAR11) were used to amplify PPARg1-a. A set of primers (PPAR8 and PPAR12) were used for ampli®cation of PPARg1-b. The location of these primers is shown indicated in Figure 1A . M muscle; F subcutaneous adipose tissue; L liver; H heart; K kidney; S stomach; D duodenum; C colon.
K Hotta et al weight prior to initiation of insulin therapy. Without these four outliers, the correlation was even greater (r 0.860, P`0.001). The ratio of PPARg2 mRNA to total PPARg mRNA also showed a high correlation to fasting plasma insulin (r 0.721, P`0.001) ( Figure  6D ). Neither PPARg1 nor PPARg2 mRNA levels, which were calculated from the slot blot analysis data and RT-PCR data (%PPARg2), were correlated to body weight (PPARg1 vs body weight; r 70.260, PPARg2 vs body weight; r 0.349). There were no signi®cant differences in the mRNA levels of total PPARg between subcutaneous and omental adipose tissue ( Figure 7A ). The ratio of PPARg2 mRNA to total PPARg mRNA also did not show signi®cant differences between subcutaneous and omental adipose tissue ( Figure 7B ).
Discussion
Obesity frequently develops in middle aged rhesus monkeys and is accompanied by both increased cell number and increased cell size. 3 Thus, adipocyte differentiation from precursor cells in adipose tissue occurs during the development of obesity. PPARg plays an important role in adipocyte differentiation. Expression of PPARg2 stimulated adipose differentiation of cultured ®broblasts. 13 Ectopic expression of PPARg and CaEBPa in myoblasts, inhibited normal myogenesis and stimulated adipogenesis.
14 PPARg has been suggested to be not only a key factor required for adipocyte differentiation, but also important for maintaining the expression of fat-speci®c genes and the adipocyte phenotype.
4±6, 38 Thus, in Figure 4 Correlations between PPARg, C/EBPa, LPL, GLUT4, aP2 and PEPCK mRNA levels in subcutaneous adipose tissue and body weight. The amount of mRNA was measured by slot blot hybridization. s; normal, u; obese, *; type 2 diabetic monkeys. A, PPARg; B, C/EBPa; C, LPL; D, GLUT4; E, aP2; F, PEPCK. NS not statistically signi®cant.
Expression of PPARg1 and PPARg2 in obese monkeys K Hotta et al order to investigate the role of PPARg in obesity in vivo, we cloned monkey PPARg cDNAs and examined mRNA expression in rhesus monkeys, which had been well-characterized for their obesity and type 2 diabetes. In monkeys, the ratio of PPARg2 mRNA to total PPARg mRNA was correlated to body weight (adiposity), whereas, neither total PPARg, nor PPARg1, nor PPARg2 mRNA level were correlated to body weight. The mRNA levels of both PPARg1 and PPARg2 in the adipose tissue were modestly increased in toxigene-induced brown fat ablated mice, but were not increased in obaob and gold thioglucose treated mice. 12 The mRNA level of PPARg2, but not PPARg1, increased in the adipose tissue of obese humans. 23 Thus, the expression of PPARg mRNA in obesity showed some differences among species and strains. Other adipocyte differentiation related genes, that is CaEBPa, LPL and GLUT4, did not increase in the adipose tissue of obese monkeys. In contrast to rhesus monkeys, the mRNA levels of CaEBPa, LPL and GLUT4 are increased in genetically obese and ventromedial hypothalamus (VMH) lesions rodents. 39±43 Again, there are species differences in the mRNA expression of these genes. It is not clear what these species differences mean. However, high mRNA expression of total PPARg, CaEBPa, GLUT4 and LPL may not be related to the obese phenotype in rhesus monkeys. Figure 5 Correlations between PPARgm RNA level, and C/EBPa, LPL, GLUT4, aP2 and PEPCK mRNA levels in subcutaneous adipose tissue. The amount of mRNA was measured by slot blot hybridization. s; normal, u; obese, *; type 2 diabetic monkeys. A, C/EBPa; B, LPL; C, GLUT4; D, aP2; E, PEPCK. NS not statistically signi®cant.
Expression of PPARg1 and PPARg2 in obese monkeys K Hotta et al
During adipocyte differentiation, coordinate transcriptional activation of many genes, including PPARg, CaEBPa, LPL and GLUT4, occurs to acquire and maintain the adipocyte phenotype. 4±6,10,11,18 Coordinate down-regulation of PPARg, CaEBPa and GLUT4 have been demonstrated in adipocytes treated by tumor necrosis factor-a (TNF-a). 44±46 We observed that the mRNA levels of CaEBPa, LPL and GLUT4 were highly correlated to the mRNA level of total PPARg, PPARg1 and PPARg2. These results suggest that the mRNA levels of PPARg, CaEBPa, LPL and GLUT4 mRNA may also be coordinated in vivo in adipose tissue. The expression of aP2 was increased during adipocyte differentiation and down regulated in adipocytes treated with TNF-a. 44, 45 The mRNA levels of aP2 and PEPCK, which are regulated by PPARg, 15, 16 were not correlated to the mRNA levels of total PPARg, PPARg1 or PPARg2. Thus, not all adipocyte differentiation related genes are coordinated in vivo in adipose tissue. Transcription factors which are involved in adipocyte differentiation, such as adipose determination differentiation factorasterol response element (SRE) binding protein (ADD1aSREBP1), CaEBPb and CaEBPd, 5, 6, 47, 48 including PPARg and CaEBPa, or other unknown factors, may co-regulate transcription of these genes. Higher correlations of the mRNA levels of CaEBPa, LPL and GLUT4, to that of PPARg1 were observed than to that of PPARg2. Although the mRNA levels of the two PPARg isoforms were not related to obesity in rhesus monkeys, our data suggested that coordinate expression of some genes, including PPARg (especially PPARg1 isoforms) may exist in vivo in adipose tissue as described in 3T3L-1 cell lines.
The ratio of PPARg2 mRNA to total PPARg mRNA was correlated to body weight (adiposity) and hyper- Figure 6 Analysis of the ratio of PPARg mRNA to total PPARg mRNA (%PPARg2). A, PCR analysis of the ratio of PPARg2 mRNA to total PPARg mRNA. Varying ratios of in vitro synthesized RNA corresponding to PPARg1 and PPARg2 were mixed, and RT-PCR was performed using the primers, PPAR8, PPAR9 and PPAR10, as described under methods. PCR products were separated on 8% polyacrylamide gel. B, Plot of data generated for the experiment shown in A. C, Correlation between the ratio of PPARg2 mRNA to total PPARg mRNA in subcutaneous adipose tissue and body weight. D, Correlation between the ratio of PPARg2 mRNA to total PPARg mRNA in subcutaneous adipose tissue and fasting plasma insulin. The ratio of PPARg2 mRNA to total PPARg mRNA was measured as described under methods. s; normal, u; obese, *; type 2 diabetic monkeys.
Expression of PPARg1 and PPARg2 in obese monkeys K Hotta et al insulinaemia, as recently reported in humans. 23 Obesity in rhesus monkeys is accompanied by insulin resistance and hyperinsulinaemia. 49 It is not clear whether the high ratio of PPARg2 mRNA to total PPARg mRNA is related to the degree of obesity or to the hyperinsulinaemia. We performed the euglycaemic hyperinsulinaemic clamp using ®ve normal, four obese and two type 2 diabetic monkeys. Neither the mRNA level of total PPARg nor the ratio of PPARg2 mRNA to total PPARg mRNA changed during a 2 h euglycaemic, hyperinsulinaemic clamp (data not shown). We cannot exclude the possibility that PPARg mRNA may increase after a clamp of longer duration than 2 h. In the mouse, the expression of PPARg1 and of PPARg2 were down-regulated by fasting and insulin-de®cient experimentally induced diabetes. 12 On the other hand, insulin alone had no effect on the mRNA expression of PPARg in isolated human adipocytes. 23 Thus, regulation of the ratio of PPARg2 mRNA to total PPARg mRNA by insulin still remains unclear.
The data of monkeys and humans 23 suggest that the ratio of PPARg1 and PPARg2 may be important to obesity, unlike in the mouse. 12 Vidal-Puig et al 23 have reported that PPARg possesses a ligand-independent NH 2 terminal activation domain and that this activity is greater for the NH 2 -terminus of PPARg2 than for PPARg1. There may be some functional differences between these two isoforms. The increased ratio of PPARg2 mRNA to total PPARg may be important to the development or maintenance of obesity in monkeys and humans. Furthermore, the N-terminal region which is speci®c to PPARg2 was relatively less conserved between primates (human and monkey) and mouse, compared to the other region of PPARg2, which is common to PPARg1. Further investigations are necessary to elucidate this difference, however, the ligand-independent activity of PPARg2 may be different between primates and rodents.
PPARg is a receptor for the thiazolidinediones that increase the sensitivity of target tissues to the action of insulin. 21 PPARg mRNA is expressed mainly in the adipose tissue and at lower levels in the muscle of the monkey, the human and the mouse. 10±13,23,25,37 Adipose tissue is one of the insulin target tissues. However, it is not clear how PPARg in adipose tissue or in muscle, function in insulin resistance. Obese rhesus monkeys are insulin resistant and hyperinsulinaemic, 49 and the ratio of PPARg2 mRNA to total PPARg mRNA was highly correlated to obesity and to fasting plasma insulin. Thus, there is a possibility that the high ratio of PPARg2 mRNA to total PPARg mRNA in the adipose tissue of obese monkeys may be related to insulin resistance.
There are some reports that the accumulation of intra-abdominal visceral fat is more closely related to the metabolic complications of obesity and diabetes, compared to the amount of subcutaneous fat. 50, 51 The PPARg mRNA levels and the ratio of PPARg2 to total PPARg, were shown to be the same in the two regions, suggesting that PPARg may not be related to the possible metabolic differences between these adipose tissue depots.
We have shown that the ratio of PPARg2 mRNA to total PPARg mRNA is highly correlated to body weight and to fasting plasma insulin. We have also shown that the mRNA levels of both PPARg isoforms (especially PPARg1) and those of CaEBPa, LPL and GLUT4 were highly correlated. Our present data suggest the possibility that the ratio of PPARg2 to total PPARg may be related to maintenance of the obese phenotype in vivo and that the mRNA levels of PPARg, CaEBPa, LPL and GLUT4 may also be coordinated in vivo in adipose tissue as described in 3T3L-1 cell lines. Figure 7 A, The mRNA levels of total PPARg and B, the ratio of PPARg2 mRNA to total PPARg mRNA (%PPARg2) in subcutaneous and omental adipose tissue. s; normal, u; obese, ; type 2 diabetic monkeys.
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